Protonix Injection, Powder, For Solution
Product Images NDC 0008-0923

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Protonix (NDC 0008-0923). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Protonix Iv 01)

FDA Label Image

Principal Display Panel (40 mg Vial Label)

Principal Display Panel (40 mg Vial Label)
Pfizer, a pharmaceutical company, distributes its products to hospitals through its subsidiary Wyeth Pharmaceuticals LLC based in Philadelphia, PA 19101.*
FDA Label Image

Principal Display Panel (40 mg Vial Carton)

Principal Display Panel (40 mg Vial Carton)
PROTONIX LV is a medication that is available in a 40mg/vial strength for intravenous infusion only. The medication contains pantoprazole sodium and is stored at a temperature between 20°C- 25°C. It is essential to protect from light and keep it in the packaging. It comes in a single-dose vial and requires reconstitution to administer. This medication is distributed by Wyeth Pharmaceuticals LLC and is under license from Takeda GmbH. Detailed dosage and administration instructions are provided in the package insert.*
FDA Label Image

Principal Display Panel (25 Vial Carton)

Principal Display Panel (25 Vial Carton)
PROTONIX®LV (pantoprazole sodium) for Injection is a sterile solution intended for intravenous infusion only. Each vial contains 40 mg/vial of pantoprazole and is a single dose vial. The solution must be reconstituted before administration. The medication is used for intravenous infusion only; it is not intended for oral or intramuscular use. PROTONIX®LV should be stored at 20°-25°C (68°-77°F); persons are permitted to store it at 15°-30°C (59°-86°F). Protective measures must be taken to safeguard the vials from light, and the use of vial carton is recommended. Contains 1 mg edetate disodium. A filter is not required. Wyeth Pharmaceuticals LLC produces it and has its headquarters in Philadelphia, PA, and under license from Takeda GmbH, D7B467 Konstanz, Germany.*
FDA Label Image

Principal Display Panel (10 Vial Carton Package Label)

Principal Display Panel (10 Vial Carton Package Label)
PROTONIX LV is a medication that comes in vials, each containing 40 mg of pantoprazole sodium, intended for intravenous infusion only. The medication is distributed by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., and made under license from Takeda GmbH. The medication should be stored at a temperature between 20°C to 25°C and protected from light. Each vial also contains 1mg of edetate disodium.*
FDA Label Image

Protonix Iv 06

Protonix Iv 06
PROTONIX® LV (pantoprazole sodium) is a sterile injection used for intravenous infusion that comes in single-dose vials containing 40mg/vial of Pantoprazole sodium (equivalent to 45.1 mg of pantoprazole sodium). It also contains 1 mg edetate disodium to be stored at 20°-25°C (68°-77°F); excursions permitted to 15°-30°C (59°-86°F). It needs to be protected from light, and the use of vial carton is recommended. PROTONIX® LV is distributed by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc, under license from Takeda GmbH, and is made in France. The product details also include a lot number and an expiration date.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.